Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric Patients

Publication ,  Conference
Prasad, VK; Grimley, M; Papanicolaou, G; Yu, LC; Florescu, DF; Brundage, TM; Mommeja-Marin, H; Kurtzberg, J
Published in: Biology of Blood and Marrow Transplantation
February 2014

Duke Scholars

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2014

Volume

20

Issue

2

Start / End Page

S93 / S93

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Prasad, V. K., Grimley, M., Papanicolaou, G., Yu, L. C., Florescu, D. F., Brundage, T. M., … Kurtzberg, J. (2014). Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric Patients. In Biology of Blood and Marrow Transplantation (Vol. 20, pp. S93–S93). Elsevier BV. https://doi.org/10.1016/j.bbmt.2013.12.121
Prasad, Vinod K., Michael Grimley, Genovefa Papanicolaou, Lolie C. Yu, Diana F. Florescu, Thomas M. Brundage, Herve Mommeja-Marin, and Joanne Kurtzberg. “Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric Patients.” In Biology of Blood and Marrow Transplantation, 20:S93–S93. Elsevier BV, 2014. https://doi.org/10.1016/j.bbmt.2013.12.121.
Prasad VK, Grimley M, Papanicolaou G, Yu LC, Florescu DF, Brundage TM, et al. Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric Patients. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2014. p. S93–S93.
Prasad, Vinod K., et al. “Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric Patients.” Biology of Blood and Marrow Transplantation, vol. 20, no. 2, Elsevier BV, 2014, pp. S93–S93. Crossref, doi:10.1016/j.bbmt.2013.12.121.
Prasad VK, Grimley M, Papanicolaou G, Yu LC, Florescu DF, Brundage TM, Mommeja-Marin H, Kurtzberg J. Brincidofovir (CMX001) Is Well Tolerated in Highly Immunocompromised Pediatric Patients. Biology of Blood and Marrow Transplantation. Elsevier BV; 2014. p. S93–S93.
Journal cover image

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2014

Volume

20

Issue

2

Start / End Page

S93 / S93

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences